KP Tissue Inc (TSE:KPT) was upgraded by equities research analysts at Royal Bank Of Canada from a “sector perform” rating to an “outperform” rating in a note issued to investors on Monday. The firm currently has a C$17.00 price objective on the stock, up from their prior price objective of C$15.00. Royal Bank Of Canada’s price objective would suggest a potential upside of 12.66% from the company’s current price.

KPT has been the topic of a number of other research reports. Scotiabank upgraded KP Tissue from a “sector perform” rating to an “outperform” rating and lifted their target price for the stock from C$14.00 to C$16.50 in a research report on Thursday, August 11th. CIBC lifted their target price on KP Tissue from C$15.00 to C$16.00 in a research report on Friday, August 12th. TD Securities reiterated a “buy” rating and set a C$15.00 target price on shares of KP Tissue in a research report on Thursday, August 11th. Finally, Desjardins upgraded KP Tissue from a “hold” rating to a “buy” rating and lifted their target price for the stock from C$13.50 to C$15.00 in a research report on Thursday, August 11th. One research analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. KP Tissue currently has an average rating of “Buy” and an average target price of C$16.21.

Analyst Recommendations for KP Tissue (TSE:KPT)

KP Tissue (TSE:KPT) opened at 15.09 on Monday. The stock’s market cap is $137.18 million. KP Tissue has a 12 month low of $9.70 and a 12 month high of $15.10. The firm’s 50-day moving average price is $14.24 and its 200-day moving average price is $13.41.

TRADEMARK VIOLATION WARNING: “KP Tissue Inc (KPT) Rating Increased to Outperform at Royal Bank Of Canada” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another domain, it was illegally copied and republished in violation of US & international copyright and trademark laws. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2016/11/30/kp-tissue-inc-kpt-rating-increased-to-outperform-at-royal-bank-of-canada.html.

About KP Tissue

KP Tissue Inc is created to acquire, and its business is limited to holding, a limited partnership interest in Kruger Products L.P. (KPLP). KPLP is a tissue products supplier, which produces, distributes, markets and sells bathroom tissue, facial tissue, paper towels and napkins, for both the Consumer and the Away-From-Home (AFH) markets.

Receive News & Stock Ratings for KP Tissue Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue Inc and related stocks with our FREE daily email newsletter.